Paul Fry
Tracked across 1 events · 7 articles · First seen Sep 14, 2026 · Last active Sep 15, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Avacta Group Therapeutics, a clinical-stage biopharmaceutical company listed on AIM under ticker AVCT, announced on September 14, 2026 the appointment of seasoned biotechnology finance executive Mats Blom to its Board of Directors as a non-executive…
Impact: Current Audit Committee Chair stepping down from the Avacta Group board effective September 30, 2026, after seven years of service, enabling an orderly handover to Blom.
Sep 14, 2026 · 7 articles
60
Paul Fry stepped down Avacta GroupAvacta Appoints Mats Blom...
ERGEN INTELLIGENCE
Track Paul Fry live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard